| Acne |
No |
| Active substance |
Donepezil |
| Also known as |
Donepezil hydrochloride |
| Aromatization |
No |
| Blood pressure |
Little to no effect |
| Chemical name |
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one |
| Dosage (medical) |
Typically 5 mg once daily, may increase to 10 mg once daily after 4-6 weeks |
| Dosage (sports) |
Not applicable |
| Effects |
Improves cognition and behavior in Alzheimer's disease |
| Formula |
C24H29NO3 |
| Half-life |
Approximately 70 hours |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
Blood levels of donepezil can be measured, though not routinely done |
| Main action |
Increases acetylcholine concentrations by inhibiting acetylcholinesterase |
| Side effects |
Nausea, diarrhea, insomnia, muscle cramps, fatigue, vomiting |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Cholinesterase inhibitor |
| Trade name |
Aricept |
| Use in sports |
None |
| WAREHOUSE |
International Warehouse 2 |
| Water Retention |
No |
| Manufacturer |
Pfizer |
